ReviewBioengineering (Basel, Switzerland)2026
Ultrasound Patches Toward Intelligent Theranostics: From Flexible Materials to Closed-Loop Biomedical Systems.
Review in Bioengineering (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Ultrasound patches represent a transformative advancement beyond conventional ultrasonography, evolving into intelligent theranostic systems for personalized healthcare. This evolution is propelled by synergistic innovations in flexible piezoelectric materials and integrated designs. The development of piezoelectric polymers, lead-free ceramics, and bio-composite materials has laid the foundation for long-term, conformal, and biosafe interfacing with the human body. Structurally, miniaturized transducer arrays (e.g., CMOS-integrated arrays achieving ~200 μm focal spots and 100 kPa focal pressure), multimodal integration, and bioinspired interfaces have enabled high-precision deep-tissue sensing and spatiotemporally controlled energy delivery-exemplified by strain-sensing feedback improving the signal-to-noise ratio by 5 dB for precise neuromodulation. These capabilities are converging to create closed-loop platforms, as demonstrated in continuous cardiovascular monitoring (up to 164 mm depth for 12 h), image-guided neuromodulation for neurological disorders, on-demand drug delivery (achieving 100% higher plasma concentration than ultrasound alone), and integrated tumor therapy with real-time feedback. Despite persistent challenges in material biocompatibility, energy efficiency, and clinical standardization, the future of ultrasound patches lies in their deep integration with multimodal sensing, machine learning, and adaptive control algorithms. This path will ultimately realize their potential for intelligent, closed-loop theranostics in chronic disease management, telemedicine, and personalized therapy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.